Withdrawal of oxyphenbutazone: what about phenylbutazone?
作者信息
Biron P
出版信息
CMAJ. 1986 May 15;134(10):1119-20.
Abstract
摘要
相似文献
1
Withdrawal of oxyphenbutazone: what about phenylbutazone?奥昔芬布宗停药：那保泰松呢？
CMAJ. 1986 May 15;134(10):1119-20.
2
Butazones under fire.保泰松受到抨击。
Lancet. 1985 Mar 9;1(8428):580. doi: 10.1016/s0140-6736(85)91238-3.
3
Anti-inflammatory drugs under fire.抗炎药物受到抨击。
Lancet. 1985 Feb 16;1(8425):410. doi: 10.1016/s0140-6736(85)91437-0.
4
Phenylbutazone, oxyphenbutazone labeling revised.保泰松、羟基保泰松标签修订。
FDA Drug Bull. 1984 Dec;14(3):23-4.
5
Contact sensitivity to oxyphenbutazone (Tanderil) and cross-sensitivity to phenylbutazone (Butazolidine).
Contact Dermatitis. 1975 Dec;1(6):385-6.
6
Phenylbutazone and oxyphenbutazone: time to call a halt.保泰松和羟布宗：是时候叫停了。
Drug Ther Bull. 1984 Jan 27;22(2):5-6.
7
Generalized pustular psoriasis precipitated by phenylbutazone and oxyphenbutazone.由保泰松和羟基保泰松诱发的泛发性脓疱型银屑病。
Br J Dermatol. 1983 Jul;109(1):111-3. doi: 10.1111/j.1365-2133.1983.tb04000.x.
8
Fixed drug eruption to oxyphenbutazone and phenylbutazone.对羟基保泰松和保泰松的固定性药疹。
Dermatologica. 1972;144(4):214-6. doi: 10.1159/000252130.
9
Phenylbutazone, oxyphenbutazone and aplastic anaemia.保泰松、羟保泰松与再生障碍性贫血
Br Med J. 1977 Jul 23;2(6081):265. doi: 10.1136/bmj.2.6081.265.
10
Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone.关于保泰松和羟基保泰松所致致命性骨髓抑制的研究
Br Med J. 1977 Jun 11;1(6075):1500-5. doi: 10.1136/bmj.1.6075.1500.
本文引用的文献
1
Correlation between ossification and inflammation using a rat experimental model.使用大鼠实验模型研究骨化与炎症之间的相关性。
J Rheumatol Suppl. 1983 Dec;11:114-7.
2
Identification of adverse reactions to new drugs. I: What have been the important adverse reactions since thalidomide?新药不良反应的识别。I：自沙利度胺事件以来有哪些重要的不良反应？
Br Med J (Clin Res Ed). 1983 Jan 15;286(6360):199-202. doi: 10.1136/bmj.286.6360.199.
3
Non-steroidal anti-inflammatory drugs. Current status and rational therapeutic use.非甾体抗炎药。现状与合理治疗应用。
Drugs. 1984 Mar;27(3):232-55. doi: 10.2165/00003495-198427030-00004.
4
Rare adverse reactions to nonsteroidal antiinflammatory drugs.非甾体抗炎药罕见的不良反应。
J Rheumatol. 1985 Feb;12(1):13-20.
5
Rare toxicity with nonsteroidal antiinflammatory drugs.
J Rheumatol. 1985 Feb;12(1):1-3.
6
Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone.关于保泰松和羟基保泰松所致致命性骨髓抑制的研究
Br Med J. 1977 Jun 11;1(6075):1500-5. doi: 10.1136/bmj.1.6075.1500.
7
Retardation of ossification of the lumbar vertebral column in ankylosing spondylitis by means of phenylbutazone.
Scand J Rheumatol. 1976;5(1):60-4.
Zotero 插件